Author:
Li Jing,Ma Zi-yue,Cui Yun-feng,Cui Ying-tao,Dong Xian-hui,Wang Yong-zhen,Fu Yu-yang,Xue Ya-dong,Tong Ting-ting,Ding Ying-zi,Zhu Ya-mei,Huang Hai-jun,Zhao Ling,Lv Hong-zhao,Xiong Ling-zhao,Zhang Kai,Han Yu-xuan,Ban Tao,Huo Rong
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine
Reference47 articles.
1. De Rosa F, Boncompagni F, Calvelli A, Paci A, Guzzo D, Fascetti F, et al. [Ventricular arrhythmias in the acute phase of myocardial infarct and in the postinfarct. A 1-year follow-up]. G Ital Cardiol. 1990;20:607–14.
2. Wasson S, Reddy HK, Dohrmann ML. Current perspectives of electrical remodeling and its therapeutic implications. J Cardiovasc Pharmacol Ther. 2004;9:129–44.
3. Liu M, Liu H, Parthiban P, Kang GJ, Shi G, Feng F, et al. Inhibition of the unfolded protein response reduces arrhythmia risk after myocardial infarction. J Clin Invest. 2021;131:e147836.
4. Kang GJ, Xie A, Liu H, Dudley SC, Jr. MIR448 antagomir reduces arrhythmic risk after myocardial infarction by upregulating the cardiac sodium channel. JCI Insight. 2020;5:e140759.
5. Ufret-Vincenty CA, Baro DJ, Lederer WJ, Rockman HA, Quinones LE, Santana LF. Role of sodium channel deglycosylation in the genesis of cardiac arrhythmias in heart failure. J Biol Chem. 2001;276:28197–203.